Tag: ASCO
RGCIRC hosts Breast Cancer Update Conference 2024
The conference showcases groundbreaking advances in cancer research, recognizes key findings from global forums
Sun Pharma to present results of the Phase III PIVOTAL trial...
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy